Loading....
Stop traffic in the Big Apple with TEAM DEBRA on Sunday March 17, 2024 in the United Airlines NYC Half! The 13.1-mile course takes runners from around the world on a tour of NYC. Help TEAM DEBRA fulfill it's mission and end Epidermolysis Bullosa (EB), "the worst disease you've never heard of". Interested in running in the 2023 United Airlines NYC Half? Email [email protected] or call (212) 868-1573 x 102 to learn more. Guaranteed Entry and Bib Number, $130 for NYRR members, $145 for non-members with a fundraising minimum of $1,500.
To support a runner or a team please enter the runner's name or the team name below.
Runner Benefits:
Runner Expectations:
What is EB?
Epidermolysis Bullosa (EB) is a group of rare disorders caused by a mutation in one of 18 genes. People with EB share the lifelong challenge of extremely fragile skin that blisters and tears from minor friction or trauma. The list of medical complications EB causes may be long and often requires multiple interventions from a range of medical specialists. There is no cure for EB but there are treatments that help alleviate some of the debilitating symptoms of certain types of EB. debra of America’s work led to the groundbreaking U.S. FDA approval of the first two treatments for EB in 2023.
To learn more please visit here.
What is debra of America?
Our mission is to improve the lives of those impacted by Epidermolysis Bullosa (EB) — “The Worst Disease You’ve Never Heard Of.” We integrate direct-to-patient programs and services, education, advocacy, close partnership with treatment developers, and research funding to foster meaningful change for those living with EB. Each year, debra of America spends an average of $1.5 million on direct-to-patient programs and services to provide immediate relief to thousands of families across the country.
Progress
2024 United Airlines NYC Half
Sunday, March 17, 2024
2024 United Airlines NYC Half
Sunday, March 17, 2024
2024 United Airlines NYC Half
Sunday, March 17, 2024
You're all set. A copy of your receipt will be emailed to you.